iShares Nasdaq Biotechnology (IBB) option IV at low end of range
iShares Nasdaq Biotechnology (NASDAQ: IBB) 30-day option implied volatility is at 14; compared to its 52-week range of 14 to 35 after President Biden unveils first 10 drugs subject to Medicare price negotiation.
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share